Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18461033 | 0.88 | GRM4 (0.34) | TP53CYP3A4GRM4 | |
| SCHEMBL18403207 | 0.78 | PPM1B (0.32) | — | |
| SCHEMBL18913786 | 0.78 | GRM4 (0.34) | TP53CYP3A4GRM4 | |
| SCHEMBL16882718 | 0.77 | PPM1B (0.31) | — | |
| SCHEMBL21581069 | 0.77 | ALDH1A1 (0.30) | — | |
| SCHEMBL25127023 | 0.76 | TP53 (0.33) | TP53CYP3A4 | |
| SCHEMBL21508993 | 0.76 | EPHX2 (0.34) | — | |
| SCHEMBL23959837 | 0.76 | AOC3 (0.34) | AOC3TP53CYP3A4HDAC3HDAC1 | |
| SCHEMBL12456296 | 0.76 | GRM4 (0.33) | GRM4 | |
| SCHEMBL23811147 | 0.75 | PPM1B (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212133-A1 | Safe, Environmentally Friendly and Controllable Method for Preparing Cycloaliphatic Diepoxides | JIANGSU TETRA NEW MATERIAL TECHNOLOGY CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212133-A1 | Safe, Environmentally Friendly and Controllable Method for Preparing Cycloaliphatic Diepoxides | DDT, EPHX2, HSD11B2 | AOC3 125/4885TP53 4187/4885CYP3A4 609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.